Royalty Pharma Plc Class A
(NASDAQ: RPRX)

Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.

39.190 s

+0.040 (+0.10%)
Range 39.085 - 39.370   (0.73%)
Open 39.150
Previous Close 39.150
Bid Price 32.360
Bid Volume 11
Ask Price 32.360
Ask Volume 9
Volume 202,911
Value -
Remark s
Delayed prices. Updated at 05 Dec 2025 23:05.
Data powered by
View All Events

About Royalty Pharma A

Repros Therapeutics, Inc. is a United States-based company that develops products and services for the management of reproductive health. The Company's products include: contraceptives, vaccines for prostate cancer, enhanced topical treatment for genital herpes as well as treatments for male and female sexual dysfunction. It focuses on the development of oral small molecule drugs to address major unmet medical needs in male and female health.

Loading Chart...

Please login to view stock data and analysis